Kyung NAM Pharm seeks alternative funding after withdrawing rights offering
Predicted impact: Low
Funding search after rights offering withdrawal already reported in recent items
Kyung NAM Pharm경남제약
053950 · KOSDAQ · ₩053950 · 경남제약
₩1,774▲ ₩14 (0.80%)End-of-day · Oct 28, 2026 · End-of-day prices.
Price · 1Y −39.45%
- Market cap
- ₩35B
- Enterprise value
- ₩22B
- P/E
- —
- P/B
- 0.3×
- Dividend yield
- 0.0%
- ROE
- −14.7%
- Net margin
- −24.5%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−68.2% from the high
₩1,415Today: ₩1,755 – ₩1,835₩5,580
Returns
- 1W−3.8%
- 1M−15.3%
- 3M+23.6%
- 6M−53.9%
- YTD−47.7%
- 1Y−39.5%
- Volume today
- 39,918
- 0.2× the 20-day average
- Traded today
- ₩72M
- Listed shares
- 19,619,649
- EPS (12 months)
- −₩783
- Earnings yield −44.1%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 25 of 100 (50 is a normal day for this stock).
- SentimentNegativeNews: Withdrawing a fundraising plan and changing product timing are seen as setbacks. Community: 0 bullish, 0 bearish posts this week.
- MomentumWeak-10% over the last month; the price is below its 20-day average.
- News impactSome4 news items and filings in two weeks; 0 rated high impact, 3 medium.
Signals describe activity, not recommendations. Not financial advice.
Kyung NAM Pharm stock overview
Kyung NAM Pharm (경남제약, KRX: 053950) is listed on KOSDAQ, in the Biotech & Pharma sector. , Ltd. Its shares closed at ₩1,774 on Oct 28, 2026, up 0.80% on the day, giving it a market value of ₩35B.
Key facts
- Market cap
- ₩35B
- Sector
- Biotech & Pharma
- Latest price change
- +0.80%
- As of
- Oct 28, 2026
- Main business
- , Ltd.
Quick answers about Kyung NAM Pharm
- What does Kyung NAM Pharm do?
- , Ltd. manufactures and wholesales/retails pharmaceuticals and active pharmaceutical ingredients, and manufactures and sells health functional foods. Its main products span vitamins, over-the-counter drugs, placenta-based products and health foods, including the Lemona vitamin powder and the Jahasaengryeok tonic drink, and it sells through about 11 branches and wholesalers to pharmacies across Korea, as well as convenience stores, large marts and health-and-beauty stores.
- What is the market cap of Kyung NAM Pharm?
- The market capitalisation of Kyung NAM Pharm was ₩35B at the close on Oct 28, 2026.
- Who are the largest shareholders of Kyung NAM Pharm?
- According to the latest official filings, the largest reported holders are Billions (21.83%, as of Jul 8, 2026); X (20.34%, as of Jul 3, 2026); Minish Technology (14.48%, as of Aug 20, 2026).
- When is the next earnings report from Kyung NAM Pharm?
- Korean companies rarely announce results dates in advance. Based on when Kyung NAM Pharm filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
Kyungnam Pharm Co., Ltd. manufactures and wholesales/retails pharmaceuticals and active pharmaceutical ingredients, and manufactures and sells health functional foods. Its main products span vitamins, over-the-counter drugs, placenta-based products and health foods, including the Lemona vitamin powder and the Jahasaengryeok tonic drink, and it sells through about 11 branches and wholesalers to pharmacies across Korea, as well as convenience stores, large marts and health-and-beauty stores.
Written by AI from the company's latest annual report.
- Korean name
- 경남제약
- Sector
- Biotech & Pharma
- Themes
- Pharmaceuticals
- CEO
- 김성곤
- Founded
- Dec 1998
- Listed
- Nov 2001
- Listed shares
- 19,619,649
- Fiscal year ends
- Month 12
- Website
- www.kyungnampharm.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,372,000−0.15%
- Celltrion068270 · ₩44T₩189,800+0.64%
- Alteogen196170 · ₩16T₩223,000+2.06%
- SK biopharmaceuticals326030 · ₩5.9T₩75,200+0.40%
- Yuhan000100 · ₩5.7T₩77,300−3.38%
- HLB028300 · ₩5.4T₩40,650+1.88%
- Hanmi Pharm128940 · ₩4.7T₩369,500+5.42%
- SAM Chun Dang Pharm000250 · ₩4.5T₩190,000+1.28%
Recent news
[The Bell] Kyung NAM Pharm reviews new fundraising plan
Predicted impact: Medium
Withdrawal of rights offering and new fundraising review; related rights offering news already in the past 14 days.
Kyung NAM Pharm withdraws rights offering, reviews new fundraising and adjusts new product schedule
Predicted impact: Medium
Withdrawn rights offering and new fundraising review; prior rights offering news already seen.
Recent filings
See all- Rights offering (paid-in capital increase) decisionOct 12, 2026
- Withdrawal NoticeOct 12, 2026
- Amended: Rights offering (paid-in capital increase) decisionOct 12, 2026
- [Amended] Notice of Shareholder Register Closure Period or Record Date SettingSep 18, 2026
- Amended: Rights offering (paid-in capital increase) decisionSep 18, 2026
Titles in Korean until English translations are added.
Also known as: Kyung NAM Pharm / 경남제약 / 053950 / KRX:053950
Source: KRX statistical information